Skip to content
Review

Modulation of the gut microbiota by traditional Chinese medicine to attenuate chemotherapy-induced toxicity in gastric cancer: a review

Oct 2026 · Supportive Care in Cancer · Vol 34 · 0 citations · 112 references
Medicine

TL;DR

TCM represents a promising microbiota-targeted strategy for mitigating chemotherapy-induced toxicities in gastric cancer through gut microbiota regulation, and future studies should focus on STING signaling and the gut–brain axis to advance evidence-based integrative oncology.

View source

Similar papers

Review Open access Oct 2026

Targeting the Microbiota–Metabolism–Immunity Axis: Active Components of Traditional Chinese Medicine in Colitis-Associated Colorectal Cancer

Colitis-associated colorectal cancer (CAC) develops in the setting of long-standing intestinal inflammation and remains a major complication of inflammatory bowel disease (IBD). Although effective control of inflammation may reduce cancer risk, approaches that specifically prevent the progression from chronic colitis t...

Qiu-Ying Chen, Han-Yi Zhang, Lei Fu et al. · 0 citations
Review Open access Sep 2026

Gut microbiota-mediated chemotherapy resistance in colorectal cancer: mechanisms and precision interventions

Colorectal cancer (CRC) is a major global health burden, and chemotherapy resistance remains a major challenge to effective treatment. Increasing evidence indicates that the gut microbiota may contribute to variability in chemotherapy response in CRC through microbial metabolism, tumor-cell adaptation, immune regulatio...

Yan Li, Fang-Rui Wang, Tao Li et al. · 0 citations
Review Open access Oct 2026

Microbiota modulation in colorectal cancer: A scoping review of its potential role in toxicity mitigation and treatment response.

Microbiota modulation is a plausible and well-tolerated adjunctive strategy in CRC, however, current evidence remains largely anchored to toxicity mitigation, while oncologic endpoints remain underexamined.

Daniel Rizky, A. Pramono, B. Setiawan et al. · 0 citations
Review Open access Sep 2026

Preclinical Evidence and Mechanisms of Traditional Chinese Medicine Polysaccharides Regulating the Gut–Lung Axis via Gut Microbiota in Respiratory Diseases

Traditional Chinese medicine (TCM) polysaccharides are important active components of traditional Chinese medicine, and their anti-inflammatory, immunomodulatory, and mucosal barrier protective effects have attracted widespread attention. Since most traditional Chinese medicine polysaccharides are difficult to be compl...

Xin-Qian Rong, Xiao-Meng Zhang, Cheng Lu et al. · 0 citations
Open access Aug 2026

The gut microbiome in chemotherapy-induced fatigue: Exploring clinical associations and modulation via fecal microbiota transplantation in female mice.

Findings are consistent with a role for gut microbes in chemotherapy-induced fatigue and suggest that FMT is not universally beneficial, with effects varying by chemotherapy drug.

Ángela Del Águila, Jeremy T. Beales, Jana L Fisher et al. · 0 citations
Review Open access Aug 2026

Therapeutic regulation of gut microbiota in gastric cancer: mechanisms, strategies, and clinical prospects

Gastric cancer (GC) is a highly prevalent malignancy associated with substantial mortality worldwide. Dysbiosis of the gut microbiota is closely linked to the pathogenesis, clinical characteristics, and therapeutic responses of GC, making it a central focus of research in the field of tumor microecology. However, exist...

Zi-Cheng Liu, Ming-Yue Bai, Li-Chao Han et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.